Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation

Transplantation Proceedings

Volumn 37, Issue 8, 2005, Pages 3354-3357

  Rodriguez E ^a   Delucchi, M A ^a   Cano, F ^a   Valdebenito, S ^a   Castillo, M C ^a   Villegas, R ^b  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ACCURACY; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CADAVER KIDNEY; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION FUNCTION; DRUG BLOOD LEVEL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; MALE; MICROEMULSION; PEDIATRIC SURGERY; PRIORITY JOURNAL;

AREA UNDER CURVE; CHILD; CHILE; CYCLOSPORINE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HOSPITALS, PUBLIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; RADIOIMMUNOASSAY;

EID: 27844469718     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.004     Document Type: Article

References (10)

1. B.D. Kahan Overview individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters Transplantation 40 1985 457
2. B.D. Kahan, M. Welsh Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic allograft rejection Transplantation 62 1996 599
3. A. Johnston, V.J. David Pharmacokinetic validation profiling Transplant Proc 32 2000 53S
4. M. Oellrrich, V.W. Armstrong, B. Kahan Lake Louise consensus meeting on cyclosporine monitoring in organ transplantation report of the consensus panel Ther Drug Monit 17 1995 642
5. M. Cantarovich, J.G. Besner Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy Clin Transplant 12 1998 243
6. P.F. Halloran, L.M. Helms The temporal profile of calcineurin inhibition by ciclosporin in vivo Transplantation 68 1999 1356
7. T. Bohler, K. Budde Pharmacodynamic monitoring of lymphocyte proliferation and TGF-beta expression of CyA through levels (C0) and 2 hours after intake (C2) of CyA in human renal allograft recipients Transplant Proc 33 2001 3148
8. J.M. Kovarik, E.A. Mueller, J.B. van Bree Cyclosporine pharmacokinetics and variability from a microemulsion formulation. A multicenter investigation in kidney transplant patients Transplantation 58 1994 658
9. G. Filler, J.H.H. Ehrich Which cyclosporin formulation? Lancet 348 1996 1176
10. Am J Clin Pathol 112 1999 358